Sign in to view content

Intravitreal Gene Therapy for Diabetic Macular Edema With ADVM-022: First-Time Data Presentation of Prospective, Randomized Phase 2 INFINITY Trial

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2021

Related

Episode 113: Journal Club, Macular Ischemia in RISE/RIDE, Wet Conversion in AMD, Micropulse for CSR
Jayanth Sridhar, MD
Member Podcasts
2018
Variability of Retinal Thickness in Diabetic macular edema (DME) Patients Treated with 0.19mg Fluocinolone Acetonide (FAc, ILUVIEN).
Christopher D. Riemann, MD
On Demand Cases, Courses, and Papers
2019
ADVM-022 Intravitreal Gene Therapy for Neovascular AMD: Phase 1 OPTIC Trial Update
Dante Joseph Pieramici, MD
Annual Meeting Talks
2022

Category: Diabetic Retinopathy

See more